Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-12 Sale | 2022-09-14 4:58 pm | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 17,344 | $2.15 | $37,290 | 0 (Direct) | View |
| 2021-07-14 Sale | 2021-07-16 6:21 pm | Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO | 34,017 | $3.71 | $126,203 | 817,806 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-01 Other | 2022-07-06 06:28 am | N/A N/A | Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 5,752,500 | $0 | 19,033,246 (Indirect) | View |
| 2022-04-08 Option Award | 2022-04-12 5:53 pm | N/A 2032-04-07 | Ovid Therapeutics Inc. | OVID | Friedman Bart Director | 69,424 | $0 | 69,424 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 5:40 pm | N/A 2023-04-07 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 97,498 | $0 | 97,498 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 5:36 pm | N/A 2032-04-07 | Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner | 423,244 | $0 | 423,244 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 5:34 pm | N/A 2032-04-07 | Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO | 204,399 | $0 | 204,399 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 5:30 pm | N/A 2032-04-07 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel Secretary | 35,399 | $0 | 35,399 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 4:55 pm | N/A 2032-04-07 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 21,347 | $0 | 21,347 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 4:44 pm | N/A 2032-04-07 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 69,424 | $0 | 69,424 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 8:51 pm | N/A 2032-02-03 | Ovid Therapeutics Inc. | OVID | Poole Robert Michael Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 8:50 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Friedman Bart Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 8:49 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 8:48 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 8:47 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 6:24 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 6:22 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO | 218,750 | $0 | 218,750 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 6:19 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel Secretary | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-04 6:14 pm | N/A 2032-02-02 | Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner | 600,000 | $0 | 600,000 (Direct) | View |
| 2021-10-06 Option Award | 2021-10-07 4:44 pm | N/A 2031-10-05 | Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-07-14 Exercise | 2021-07-16 6:21 pm | N/A 2029-02-23 | Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO | 34,017 | $0 | 817,806 (Direct) | View |
| 2021-07-14 Exercise | 2021-07-16 6:21 pm | N/A N/A | Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO | 34,017 | $1.89 | 817,806 (Direct) | View |
| 2021-07-09 Option Award | 2021-07-13 4:25 pm | N/A 2031-07-08 | Ovid Therapeutics Inc. | OVID | Poole Robert Michael Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 4:23 pm | N/A 2031-06-30 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-11 8:31 pm | N/A 2031-06-10 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-11 8:22 pm | N/A 2031-06-10 | Ovid Therapeutics Inc. | OVID | Friedman Bart Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-11 8:15 pm | N/A 2031-06-10 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-10 7:49 pm | N/A 2031-06-01 | Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-18 9:04 pm | N/A 2031-05-16 | Ovid Therapeutics Inc. | OVID | WILLIAMS DOUGLAS E Director | 1,750 | $0 | 1,750 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-18 9:00 pm | N/A 2031-05-16 | Ovid Therapeutics Inc. | OVID | Friedman Bart Director | 1,750 | $0 | 1,750 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-18 8:57 pm | N/A 2031-05-16 | Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director | 1,750 | $0 | 1,750 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-18 8:51 pm | N/A 2031-05-16 | Ovid Therapeutics Inc. | OVID | Bernstein Karen Director | 1,750 | $0 | 1,750 (Direct) | View |
| 2020-11-25 Option Award | 2021-04-29 5:32 pm | 2020-11-25 2030-05-04 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel Secretary | 44,000 | $0 | 44,000 (Direct) | View |
| 2020-11-25 Option Award | 2021-04-29 5:30 pm | 2020-11-25 2030-05-04 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 44,000 | $0 | 44,000 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-08 8:27 pm | 2021-02-05 2030-06-19 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 5:08 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 5:04 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel Secretary | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:58 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:53 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:45 pm | N/A 2030-12-16 | Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner | 650,000 | $0 | 650,000 (Direct) | View |